Pharmacovigilance companies operate under some of the most stringent regulatory timelines in the pharmaceutical industry. FDA expedited safety reporting requirements — 7-day and 15-day ICSR deadlines under 21 CFR Part 312 — leave no margin for administrative disorganization. Yet as PV companies expand their client portfolios of pharmaceutical manufacturers and biotech sponsors, the administrative overhead embedded in those client relationships is growing faster than many firms anticipated. Billing management, sponsor account administration, and safety reporting coordination are consuming staff capacity that should be directed toward signal detection and regulatory science.
Virtual assistants are providing pharmacovigilance companies with a way to manage the administrative layer systematically and cost-effectively.
Billing Complexity in Pharmacovigilance Engagements
PV company billing is not straightforward. Contracts typically involve a mix of retainer fees for ongoing safety monitoring, per-case processing fees for individual safety reports, and milestone billing for periodic safety report deliverables like PSURs and DSURs. Managing this multi-structure billing across multiple pharma and biotech sponsors requires careful tracking and consistent administration.
According to the FDA, pharmaceutical companies submitted more than 2.4 million individual case safety reports (ICSRs) through the MedWatch reporting system in 2024. For PV companies processing reports on behalf of multiple sponsors, each case represents a unit of billing activity that must be tracked, invoiced, and reconciled against contract terms.
Virtual assistants can manage the per-case and milestone billing workflows, prepare invoices for sponsor review, track purchase order balances, and follow up on payment schedules — reducing accounts receivable lag without consuming pharmacovigilance staff time.
Sponsor Account Administration and Onboarding
Onboarding a new pharmaceutical or biotech sponsor to a PV company's safety monitoring program is a structured process involving data-sharing agreements, regulatory authority notification requirements, MedWatch and EudraVigilance system access configuration, and communication protocol establishment. Each element has documentation requirements that must be captured and filed. Virtual assistants can manage the onboarding workflow — collecting and organizing required documents, tracking checklist completion, and coordinating system access setup — ensuring sponsors are activated efficiently and compliantly.
Ongoing sponsor account administration includes maintaining regulatory calendar reminders for PSUR submission windows, managing communication distribution for safety signal summaries, coordinating sponsor access to case processing portals, and organizing safety database documentation. IQVIA's 2025 Pharmacovigilance Outsourcing Report found that PV companies serving five or more active sponsors without dedicated administrative support experience 25 to 40 percent higher error rates in client communication and billing documentation.
FDA Safety Reporting Coordination
FDA adverse event reporting coordination — managing submission timelines, distributing FDA acknowledgment receipts to sponsor contacts, tracking 7-day and 15-day reporting windows, and organizing FDA correspondence archives — is high-stakes, high-frequency administrative work. Missed reporting deadlines carry serious regulatory consequences, including warning letters and potential clinical hold activity.
Virtual assistants trained to maintain regulatory reporting calendars, track ICSR submission acknowledgments, and organize FDA correspondence provide a critical layer of operational discipline. They can manage the distribution workflows that ensure sponsor safety teams receive FDA communications promptly, and maintain the documentation records that support regulatory inspection readiness.
The FDA's 2025 Drug Safety Monitoring Report highlighted that inspection findings related to ICSR documentation and reporting timeline management are among the most common post-market compliance deficiencies. Strong administrative infrastructure is a meaningful safeguard.
Building Scalable PV Operations
Pharmacovigilance companies looking to grow their client base in 2026 need administrative infrastructure that scales with new sponsor additions without requiring proportional headcount growth. Virtual assistants provide the billing, onboarding, and coordination capacity to support expanded client portfolios — at a cost structure that preserves firm economics while improving service delivery quality.
For pharmacovigilance companies ready to reduce billing overhead, systematize sponsor onboarding, and improve safety reporting coordination, Stealth Agents provides virtual assistants experienced in pharmaceutical regulatory and safety environments.
Sources
- FDA, MedWatch Safety Reporting Annual Data, 2024
- IQVIA, Pharmacovigilance Outsourcing Report, 2025
- FDA, Drug Safety Monitoring Compliance Report, 2025